Systemic Juvenile Idiopathic Arthritis With Active Flare
1 clinical trials · Condition
◉ Watch Systemic Juvenile Idiopathic Arthritis With Active Flare
| Record | Firm | Date |
|---|---|---|
| Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA) (NCT00889863) | Novartis Pharmaceuticals | 2009-07-01 |
Track Systemic Juvenile Idiopathic Arthritis With Active Flare automatically
Every clearance here is in the API, with alerts when new ones post.